Subunit Vaccine Market 2018 Size, Growth Analysis Report, Forecast to 2023

Global subunit vaccine market is anticipated to grow at the significant CAGR during the forecast period (2018-2023). Subunit vaccines work by utilizing a part of a target pathogen to initiate a response from the immune system. Subunit vaccines are manufactured by isolating a specific protein from a pathogen and presenting it as an antigen on its own or it can be manufactured via genetic engineering. Human papillomavirus (HPV) vaccine is a vaccine made using genetic engineering. At present there are two types of HPV vaccine, one which provides immunity against two strains of HPV, the other provides immunity against four strains of HPV. The acellular pertussis vaccine and influenza vaccine (in short form) are some other examples of subunit vaccines. Moreover, subunit vaccines are available for hepatitis B (HepB) vaccine, pneumococcal (PCV-7, PCV-10, PCV-13) vaccine, and Haemophilus influenza type b (Hib) vaccine. Subunit vaccines are given to people with weakened immune systems. These vaccines appear to give long-lived immunity since only parts of the virus are used for these vaccines, the risks of reactions are very low.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/subunit-vaccine-market

The factors fuelling the growth of the subunit vaccine market include increasing demand for immunization and better safety as compared to traditional vaccines.  The benefits offered by subunit vaccines such as long immunity offered and the low-risk rate associated with the subunit vaccines are propelling the market growth. The challenges associated with the production process of subunit vaccines are hindering the growth of the market.

A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/subunit-vaccine-market

Market Segmentation

Global Subunit Vaccine Market by Product Type

  • Protein Antigen
  • Polysaccharide Antigen

Global Subunit Vaccine Market by Production Type

  • Denaturing of Proteins
  • Genetic Engineering

Global Subunit Vaccine Market by Immune Responses Type

  • Antigen-Presenting Cells (APCS)
  • Cell-Mediated Immunity
  • Cytokines (Direct Th1 Or Th2 Immune Responses)
  • Mucosal
  • Others

Global Subunit Vaccine Market by Disease

  • Infectious Disease
  • Diphtheria, Tetanus and Pertussis (DTP)
  • HPV
  • Measles, Mumps and Rubella (MMR)
  • Others

Competitive Landscape

  • Key Strategy Analysis
  • Key Company Analysis

Regional Analysis

North America

  • United States
  • Canada

Europe

  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • Rest of Asia-Pacific

Rest of the World

Company profiles

  • Algenex S.L.
  • Arbutus Biopharma Corp.
  • Astellas Pharma Inc,
  • Astrazeneca PLC
  • Emergent Biosolutions
  • GE Healthcare Life Sciences
  • GlaxoSmithKline PLC
  • Indian Immunologicals Ltd.
  • QED Biosciences Inc.

Reasons to Buying From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/subunit-vaccine-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com 
Contact no: +91 780-304-0404

(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)